Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy

Adam Bohr; Thais Leite Nascimento; Necati Harmankaya; Johan Juhl Weisser; Yingya Wang; Holger Grohganz; Thomas Rades; Korbinian Löbmann

doi:10.3390/molecules24020266

Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy

Adam Bohr, Thais Leite Nascimento, Necati Harmankaya, Johan Juhl Weisser, Yingya Wang, Holger Grohganz, Thomas Rades, Korbinian Löbmann

Research output: Contribution to journal › Journal article › Research › peer-review

20 Citations (Scopus)

93 Downloads (Pure)

Original language	English
Article number	266
Journal	Molecules
Volume	24
Issue number	2
Number of pages	13
ISSN	1420-3049
DOIs	https://doi.org/10.3390/molecules24020266
Publication status	Published - 2019

Access to Document

10.3390/molecules24020266Licence: CC BY

molecules-24-00266Final published version, 2.21 MBLicence: CC BY

Cite this

Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy. / Bohr, Adam; Nascimento, Thais Leite; Harmankaya, Necati; Weisser, Johan Juhl; Wang, Yingya; Grohganz, Holger ; Rades, Thomas ; Löbmann, Korbinian.

In: Molecules, Vol. 24, No. 2, 266, 2019.

Research output: Contribution to journal › Journal article › Research › peer-review

@article{5533bc5fd9294ce296daf23adc46cbec,

title = "Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy",

author = "Adam Bohr and Nascimento, {Thais Leite} and Necati Harmankaya and Weisser, {Johan Juhl} and Yingya Wang and Holger Grohganz and Thomas Rades and Korbinian L{\"o}bmann",

year = "2019",

doi = "10.3390/molecules24020266",

language = "English",

volume = "24",

journal = "Molecules",

issn = "1420-3049",

publisher = "M D P I AG",

number = "2",

}

TY - JOUR

T1 - Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy

AU - Bohr, Adam

AU - Nascimento, Thais Leite

AU - Harmankaya, Necati

AU - Weisser, Johan Juhl

AU - Wang, Yingya

AU - Grohganz, Holger

AU - Rades, Thomas

AU - Löbmann, Korbinian

PY - 2019

Y1 - 2019

U2 - 10.3390/molecules24020266

DO - 10.3390/molecules24020266

M3 - Journal article

C2 - 30642009

VL - 24

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 2

M1 - 266

ER -